background image

Paid Clinical Trials Philadelphia

Discover 2,138 paid clinical trials in Philadelphia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas

Recruiting
PHASE2

Sponsor:

Sidney Kimmel Cancer Center at Thomas Jefferson University

Location:

Philadelphia

Code:

NCT03198026

Conditions

Non-Hodgkin's Lymphoma

Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

Ann Arbor Stage II Follicular Lymphoma

Ann Arbor Stage II Nodal Marginal Zone Lymphoma

Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ibrutinib

Obinutuzumab

Laboratory Biomarker Analysis

A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Recruiting
PHASE1
PHASE2

Sponsor:

Nuvalent Inc.

Location:

Philadelphia, New York, Baltimore, Washingtonshow 19 more

Code:

NCT05384626

Conditions

Locally Advanced Solid Tumor

Metastatic Solid Tumor

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

NVL-655

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting
PHASE3

Sponsor:

GB002, Inc.

Location:

Philadelphia, New York, Baltimore, Washingtonshow 47 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler

The Frequency of Screening and SBT Technique Trial: The FAST Trial

Recruiting

Sponsor:

Unity Health Toronto

Location:

Philadelphia, Boston, Hamilton, Torontoshow 9 more

Code:

NCT02969226

Conditions

Critically Ill

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Once daily screening

Twice daily screening

PS SBTs

T-piece SBTs

An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Recruiting

Sponsor:

XenoPort, Inc.

Location:

Philadelphia, Amherst, Toledo, Columbiashow 8 more

Code:

NCT02560766

Conditions

RLS

Eligibility Criteria

Sex: All

Age: 13 - 17

Healthy Volunteers: Not accepted

Interventions

HORIZANT 300 mg

HORIZANT 600 mg

Placebo

Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose

Recruiting
PHASE3

Sponsor:

Hamilton Health Sciences Corporation

Location:

Philadelphia, Hamilton, Ottawa, Halifax

Code:

NCT02486666

Conditions

Venous Thromboembolism

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Enoxaparin

A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

Recruiting

Sponsor:

Amicus Therapeutics

Location:

Philadelphia

Code:

NCT04252066

Conditions

Fabry Disease

Eligibility Criteria

Sex: Female

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

migalastat

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Recruiting
PHASE1
PHASE2

Sponsor:

Jazz Pharmaceuticals

Location:

Philadelphia, New York, Washington, Torontoshow 9 more

Code:

NCT05734066

Conditions

Refractory Ewing Sarcoma

Relapsed Ewing Sarcoma

Ewing Sarcoma

Eligibility Criteria

Sex: All

Age: 2 - 30

Healthy Volunteers: Not accepted

Interventions

Lurbinectedin

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

East Windsor, Brooklyn, New York, Forest Hillsshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Philadelphia, Mullica Hill, Exton, Lawrence Townshipshow 195 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

Philadelphia boasts a strong healthcare network and prominent medical research centers, making it a pivotal location for a diverse range of clinical trials. Renowned institutions such as the University of Pennsylvania, Thomas Jefferson University, and Temple University lead the way in innovative research. These centers are known for their cutting-edge studies across various fields, including oncology, cardiology, neurology, and infectious diseases.

The city’s rich tapestry of clinical research is supported by its diverse population, while the collaborative research environment in Philadelphia also fosters groundbreaking discoveries that can transform patient care and improve health outcomes on a broader scale.

Why choose Philadelphia for clinical trials?

Common conditions studied in Philadelphia

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Philadelphia